|
General Information
|
|
|
Product
|
TSLP Peptide
|
|
Description
|
Antigenic Blocking Peptide Thymic Stromal LymphoPoietin Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 50-100 on human Thymic Stromal LymphoPoietin.
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q969D9
|
|
Molecular Function
|
cytokine activity
interleukin-7 receptor binding
|
|
Subcellular Location
|
Extracellular region or secreted
|
|
Expression
|
Isoform 1 is expressed in a number of tissues including heart, liver and prostate. Isoform 2 is the predominant form in keratinocytes of oral mucosa, skin and in salivary glands. It is secreted into saliva.
|
|
Structure
|
Interacts with a receptor composed of CRLF2 and IL7R. Binding of TSLP to CRLF2/TSLPR is a mechanistic prerequisite for recruitment of IL7R to the high-affinity ternary complex.
|
|
Alternative Nomenclature
|
Thymic stromal lymphopoietin antibody
Thymic stromal lymphopoietin protein TSLP antibody
Tslp antibody
TSLP protein antibody
TSLP_HUMAN antibody
|
|
|
|
TSLP Antibody
TSLP Positive Control
TSLP Antibody FITC
TSLP Antibody BIOTIN
